17 November - 19 November 2014
SCI's Biotechnology Group in partnership with the European Federation of Biotechnology Bioengineering and Bioprocessing Section and BBSRC
SCI HQ, London, UK
This event is no longer available for registration.
Early bird registration and abstract deadline extended to Friday 31 October.
This meeting encompasses all aspects of science and engineering of industrial biotechnology. From proteins to small molecules, biopharmaceuticals to platform chemicals and biofuels, the meeting will encompass all areas of Industrial Biotechnology and Bioprocessing and will reinforce the links between processes generating diverse products.
A further aim of the meeting is to encourage collaborative links to be built throughout Europe for joint research and applications to trans-European funding schemes such as Horizon 2020.
The meeting will start with a plenary lecture entitled:
Personalised Medicine - Deciphering Cancer by Professor Carl Borrebaeck, Department of Immunotechnology, Lund University
The conference will in part be sponsored by the UK Biotechnology and Biological Sciences Research Council and will include contributions from Chairs of recently established networks of biotechnology within the UK:
There will also be a Workshop: Systems and synthetic biology for open discussion and contributions from the floor. The theme:
The deadline for oral presentation abstracts has now closed. Abstracts for Poster presentations are still being accepted, please click on the link below to register.
14/15 Belgrave Square
London, SW1X 8PS
Tel: +44(0) 20 7598 1594
SCI members will receive a discount on the delegate fees.
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email firstname.lastname@example.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.